Paper. Zorrilla E, Schindler EAD. Nature Reviews. Neurology, 17 Nov 2026.
Tags: Review, Psilocybin, LSD, DMT, Pain.
High-dose psilocybin blocked CGRP signalling and slowed head and neck tumour growth in mice.
Cutting sensory nerve signalling reduced tumour growth in orthotopic models, and CGRP knockout plus radioimmunotherapy eradicated tumours. Psilocybin acted on the same pathway, transiently shrinking tumours by boosting antitumour immunity, with plasma correlations from single-dose human subjects.
How much weight it carries: Mouse tumour models plus in vitro work, with a correlational human plasma analysis; no clinical evidence that psilocybin affects cancer outcomes. (Mice, Preclinical, Mechanism, In vitro, Review)